Management of Breast Implant Seroma
Critical First Step: Rule Out BIA-ALCL
- The American Society of Clinical Oncology recommends that any new or late-onset seroma must be aspirated and sent for cytologic evaluation to rule out breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) 1, 2, 3
- When a patient presents with breast implant seroma, the immediate priority is excluding malignancy, particularly BIA-ALCL, which is the most common presentation of this potentially fatal lymphoma 1, 4, 3
Diagnostic Workup for Seroma Fluid
- Perform ultrasound-guided aspiration of fresh, unfixed effusion fluid and send for immediate cytologic evaluation using cytocentrifugation and filtration to produce air-dried smears stained with Wright-Giemsa or other Romanowsky-type stains 1, 2, 5
- Prepare a cell block from the aspirated fluid to allow for hematoxylin and eosin staining, immunohistochemical analysis (CD30+, ALK-), and PCR-based T-cell receptor gene rearrangement testing to detect clonality 1, 4, 3
High-Risk Features Requiring Heightened Suspicion
- Textured implants, particularly Allergan BIOCELL devices, are associated with 96% of late seromas and significantly higher BIA-ALCL risk (median onset 8 years post-implantation) 1, 4, 3
- Associated mass or capsular thickening increases likelihood of malignancy 1, 3
Management Algorithm Based on Timing and Clinical Context
- Maintain surgical drains until output is <30 mL daily, but remove by 7-14 days maximum to prevent drain-associated infection (risk ratio 2.47 for infection with prolonged drains) 6, 7
- Proceed with early tissue expander inflation to decrease seroma pocket size without causing excessive skin tension 7
- Keep surgical bulb at gravity at all times to prevent drained fluid from re-entering the surgical pocket 7
Risk Factors Requiring Enhanced Surveillance
Critical Pitfalls to Avoid
- Never assume a late seroma is benign without cytologic evaluation - BIA-ALCL has caused deaths and requires early diagnosis for optimal outcomes (disease limited to effusion has indolent course; capsular invasion worsens prognosis) 1, 4, 3
- Do not extend postoperative antibiotics beyond 24 hours as this does not reduce infection rates and promotes multidrug-resistant pathogens 7
- Avoid excisional biopsy for clearly diagnosed seroma as it is unnecessarily invasive 8
- Do not rely solely on imaging - large seromas may obscure residual calcifications on mammography, and MRI can be misleading (seromas can mimic implants radiologically) 9